Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 693

1.

Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation.

Reece TB, Ellman PI, Maxey TS, Crosby IK, Warren PS, Chong TW, LeGallo RD, Linden J, Kern JA, Tribble CG, Kron IL.

J Thorac Cardiovasc Surg. 2005 May;129(5):1137-43.

2.

Adenosine A2A receptor agonist improves cardiac dysfunction from pulmonary ischemia-reperfusion injury.

Reece TB, Laubach VE, Tribble CG, Maxey TS, Ellman PI, Warren PS, Schulman AM, Linden J, Kern JA, Kron IL.

Ann Thorac Surg. 2005 Apr;79(4):1189-95.

PMID:
15797048
3.

Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion.

Fiser SM, Tribble CG, Kaza AK, Long SM, Kern JA, Cassada DC, Linden J, Rieger J, Laubach VE, Matisoff A, Kron IL.

J Thorac Cardiovasc Surg. 2002 Nov;124(5):973-8.

4.

Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model.

LaPar DJ, Laubach VE, Emaminia A, Crosby IK, Hajzus VA, Sharma AK, Sumner HM, Webb DV, Lau CL, Kron IL.

J Thorac Cardiovasc Surg. 2011 Oct;142(4):887-94. doi: 10.1016/j.jtcvs.2011.06.015.

5.

Selective adenosine-A2A activation reduces lung reperfusion injury following transplantation.

Ross SD, Tribble CG, Linden J, Gangemi JJ, Lanpher BC, Wang AY, Kron IL.

J Heart Lung Transplant. 1999 Oct;18(10):994-1002.

PMID:
10561110
6.

Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion.

Gazoni LM, Laubach VE, Mulloy DP, Bellizzi A, Unger EB, Linden J, Ellman PI, Lisle TC, Kron IL.

J Thorac Cardiovasc Surg. 2008 Jan;135(1):156-65. doi: 10.1016/j.jtcvs.2007.08.041.

7.

The evolution of ischemic spinal cord injury in function, cytoarchitecture, and inflammation and the effects of adenosine A2A receptor activation.

Reece TB, Okonkwo DO, Ellman PI, Warren PS, Smith RL, Hawkins AS, Linden J, Kron IL, Tribble CG, Kern JA.

J Thorac Cardiovasc Surg. 2004 Dec;128(6):925-32.

8.

Functional and cytoarchitectural spinal cord protection by ATL-146e after ischemia/reperfusion is mediated by adenosine receptor agonism.

Reece TB, Kron IL, Okonkwo DO, Laurent JJ, Tache-Leon C, Maxey TS, Ellman PI, Linden J, Tribble CG, Kern JA.

J Vasc Surg. 2006 Aug;44(2):392-7.

9.

Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia.

Cassada DC, Tribble CG, Long SM, Laubach VE, Kaza AK, Linden J, Nguyen BN, Rieger JM, Fiser SM, Kron IL, Kern JA.

J Vasc Surg. 2002 May;35(5):994-8.

10.

Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashion.

Cassada DC, Tribble CG, Kaza AK, Fiser SM, Long SM, Linden J, Rieger JM, Kron IL, Kern JA.

Surgery. 2001 Aug;130(2):230-5.

PMID:
11490354
11.

Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death.

Wagner CE, Pope NH, Charles EJ, Huerter ME, Sharma AK, Salmon MD, Carter BT, Stoler MH, Lau CL, Laubach VE, Kron IL.

J Thorac Cardiovasc Surg. 2016 Feb;151(2):538-45. doi: 10.1016/j.jtcvs.2015.07.075.

PMID:
26323621
12.

Adenosine A2A analogue reduces long-term neurologic injury after blunt spinal trauma.

Reece TB, Davis JD, Okonkwo DO, Maxey TS, Ellman PI, Li X, Linden J, Tribble CG, Kron IL, Kern JA.

J Surg Res. 2004 Sep;121(1):130-4.

PMID:
15313386
13.

Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease.

Odashima M, Bamias G, Rivera-Nieves J, Linden J, Nast CC, Moskaluk CA, Marini M, Sugawara K, Kozaiwa K, Otaka M, Watanabe S, Cominelli F.

Gastroenterology. 2005 Jul;129(1):26-33.

PMID:
16012931
14.

Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury.

Stammberger U, Carboni GL, Hillinger S, Schneiter D, Weder W, Schmid RA.

J Heart Lung Transplant. 1999 Sep;18(9):862-8.

PMID:
10528748
15.

Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation.

Peirce SM, Skalak TC, Rieger JM, Macdonald TL, Linden J.

Am J Physiol Heart Circ Physiol. 2001 Jul;281(1):H67-74.

16.

Edaravone attenuates ischemia-reperfusion injury by inhibiting oxidative stress in a canine lung transplantation model.

Xu JZ, Shen BZ, Li Y, Zhang T, Xu WH, Liu XW, Lu HG.

Chin Med J (Engl). 2008 Aug 20;121(16):1583-7.

PMID:
18982873
17.

The adenosine 2A receptor agonist ATL-146e attenuates experimental posthemorrhagic vasospasm.

Chang CZ, Dumont AS, Simsek S, Titus BJ, Kwan AL, Kassell NF, Solenski NJ.

Neurosurgery. 2007 Jun;60(6):1110-7; discussion 1117-8.

PMID:
17538386
18.

A selective adenosine A2A receptor agonist, ATL-146e, prevents concanavalin A-induced acute liver injury in mice.

Odashima M, Otaka M, Jin M, Horikawa Y, Matsuhashi T, Ohba R, Linden J, Watanabe S.

Biochem Biophys Res Commun. 2006 Sep 8;347(4):949-54.

PMID:
16859640
19.

Vasoactive intestinal peptide ameliorates reperfusion injury in rat lung transplantation.

Nagahiro I, Yano M, Boasquevisque CH, Fujino S, Cooper JD, Patterson GA.

J Heart Lung Transplant. 1998 Jun;17(6):617-21.

PMID:
9662098
20.

Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia.

Glover DK, Ruiz M, Takehana K, Petruzella FD, Rieger JM, Macdonald TL, Watson DD, Linden J, Beller GA.

Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H3164-71.

Items per page

Supplemental Content

Support Center